OpenBench
San Francisco, US · Founded 2019 · Delaware corporation
Find your way into OpenBench
Sign up to see every warm intro you have to OpenBench
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OpenBench team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OpenBench runs AI-enabled structure-based virtual screening to identify small molecule hit series for biotech drug discovery programs, screening large compound libraries and charging only for hits that meet a client-defined profile. It works with clients' own assays and CROs, offering a success-driven model where collaborators purchase resulting IP outright.
Founders & leadership
OpenBench was founded in 2019 by James Thompson and James Yoder.


Reported raises · per SEC filings
Form D private placements$2.7M disclosed across 3 rounds · 2020–2021
▶$2.3MraisedApr 2022 · 16 investors · Other TechnologyRule 506(b)
- James ThompsonExecutive Officer, Director, Promoter
- James YoderExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Amount sold
- $2.3M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$150KraisedApr 2021 · 6 investors · OtherRule 506(b)
- James ThompsonExecutive Officer, Director, Promoter
- James YoderExecutive Officer, Director, Promoter
- Offering amount
- $150K
- Amount sold
- $150K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$300KraisedJan 2020 · 6 investors · OtherRule 506(b)
- James ThompsonExecutive Officer, Director
- James YoderExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as OpenBench.
Frequently asked questions
- What does OpenBench do?
- OpenBench runs AI-enabled structure-based virtual screening to identify small molecule hit series for biotech drug discovery programs, screening large compound libraries and charging only for hits that meet a client-defined profile. It works with clients' own assays and CROs, offering a success-driven model where collaborators purchase resulting IP outright.
- Who founded OpenBench?
- OpenBench was founded by James Thompson, James Yoder in 2019.
- How much funding has OpenBench raised?
- OpenBench has disclosed $2.7M raised across 3 rounds.
- Where is OpenBench headquartered?
- OpenBench is headquartered in San Francisco, US.



